Can Tucatinib be purchased through formal domestic channels now?

Tucatinib, also known as tucatinib, is a targeted therapy drug developed for patients with HER2 positive cancer. It is especially suitable for the treatment of HER2 positive breast cancer and its brain metastasis. However, as of now, the original drug of tucatinib has not been officially launched in mainland China, so patients cannot directly purchase the drug through regular channels in regular domestic hospitals or pharmacies.

Because it is not marketed in China, tucatinib cannot be included in the national medical insurance directory, which means that even if patients can obtain the drug through certain special channels, they must bear the full cost out of their own pocket. In overseas markets, tucatinib has been approved by drug regulatory agencies in many countries and is widely used in clinical treatment. Especially in the European market, the original drug in 150mg*84 tablet format may be priced as high as more than 40,000 yuan, which is expensive and places a heavy burden on ordinary families.

In order to relieve the pressure of medication, some patients will choose overseas generic versions of drugs. At present, generic versions of tucatinib have been launched in Laos and other places. The common specifications are 150mg*60 tablets, and the price per box is about more than 2,000 yuan. Although the price is much more affordable than the original drug, the generic drug is basically the same as the original drug in terms of drug composition, bioequivalence, etc., and has been widely recognized as clinically substitutable.

Generally speaking, although tucatinib cannot be purchased through formal channels in China, patients can still obtain related drugs through overseas drug purchases and cross-border medical platforms. When choosing generic drugs, it is recommended to give priority to products produced by pharmaceutical factories with quality assurance and legal production qualifications to ensure drug safety and therapeutic effect.

Reference materials:https://www.drugs.com/